LinkedIn

And why did Grünenthal pull the plug on Depomed being the partner for Nucynta? If the very sales reps here complaining about being dismissed were doing their jobs, this would have never happened.

 

Dear Arthur and Joe,

The pain reps increased sales of the Nucynta brand by 15%. Remember that is what you said Arthur? 15% in 12 months in a declining opioid market! Now, let’s look at the stocking issues that took place Wayyyyyyyy before the hurricane in Puerto Rico where you so conveniently claim was because of the hurricanes. Sorry folks, I’m not a trump robot. I can actually think, remember and see things as they actually are and not what you say they are to complete your narrative. The stocking issue is all on you. Let’s take at the unrealistic projections against the silent loan that no one knew about and somewhere in between the BS and us taking your punk a##### to court will be your answers. Maybe before you get in the courtroom, you will figure out the difference between hydromorphone, oxycodone and tapentadol. Nevertheless, be prepared to pull our money out of your a## before we have to.

 

by the way a-hole “G” pulling the plug on Depomed is Change in Control. Now dig deeper into those pockets to pay your fines on intentionally defrauding the employees and your stakeholders.

 

You are right on target.

 

I heard that the whole stock fiasco is under investigation.

 

What do you mean?

 

So the lawsuits have been filed. Goodbye of what is left of Depomed. If only honesty was a virtue.

 

Dilution coming as company picks up another no nothing molecule. These guys are clueless.